Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Financials | 5.75% |
| 3 | Healthcare | 5.71% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Insulet
PODD
$10.1B
| $1.11M | ﹤0.01% |
10,463
-112,871
| -92% | -$10.6M |
|
3477
STAAR Surgical
STAA
$1.26B
| $1.11M | ﹤0.01% |
23,090
-10,313
| -31% | -$422K |
|
3478
Omeros
OMER
$1.24B
| $1.1M | ﹤0.01% |
45,202
+21,862
| +94% | +$488K |
|
|
AMAG
3479
DELISTED
AMAG Pharmaceuticals
AMAG
| $1.1M | ﹤0.01% |
55,059
+18,185
| +49% | +$414K |
|
3480
PUT
KKR & Co
KKR
$102B
| $1.1M | ﹤0.01% |
40,300
-100
| -0.2% | -$2.67K |
|
3481
CALL
Wolfspeed
WOLF
$1.6B
| $1.1M | ﹤0.01% |
29,000
+12,700
| +78% | +$577K |
|
|
ALEX
3482
DELISTED
Alexander & Baldwin
ALEX
| $1.1M | ﹤0.01% |
48,341
+28,703
| +146% | +$681K |
|
3483
ATN International
ATNI
$494M
| $1.1M | ﹤0.01% |
14,838
+8,822
| +147% | +$591K |
|
3484
MGE Energy Inc
MGEE
$3.07B
| $1.1M | ﹤0.01% |
17,167
+14,609
| +571% | +$948K |
|
|
XCRA
3485
DELISTED
Xcerra Corporation
XCRA
| $1.09M | ﹤0.01% |
76,527
-173,604
| -69% | -$2.46M |
|
3486
PUT
Ciena
CIEN
$62.6B
| $1.09M | ﹤0.01% |
34,900
-4,400
| -11% | -$123K |
|
3487
ProShares Ultra QQQ
QLD
$14.5B
| $1.09M | ﹤0.01% |
86,608
-10,400
| -11% | -$124K |
|
|
QTNA
3488
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $1.09M | ﹤0.01% |
59,009
+13,310
| +29% | +$226K |
|
|
CIVI
3489
DELISTED
Civitas Resources
CIVI
| $1.09M | ﹤0.01% |
36,521
-38,478
| -51% | -$1.28M |
|
3490
Koppers
KOP
$872M
| $1.09M | ﹤0.01% |
34,916
+23,384
| +203% | +$838K |
|
|
MITL
3491
DELISTED
Mitel Networks Corporation
MITL
| $1.09M | ﹤0.01% |
98,689
-232,717
| -70% | -$2.56M |
|
|
ESV
3492
PUT
DELISTED
Ensco Rowan plc
ESV
| $1.09M | ﹤0.01% |
32,175
-49,800
| -61% | -$1.42M |
|
|
TWO
3493
Two Harbors Investment
TWO
$1.27B
| $1.08M | ﹤0.01% |
18,171
+5,624
| +45% | +$350K |
|
|
CXO
3494
PUT
DELISTED
CONCHO RESOURCES INC.
CXO
| $1.08M | ﹤0.01% |
7,100
-109,700
| -94% | -$15.5M |
|
|
PDLI
3495
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.08M | ﹤0.01% |
413,069
+293,071
| +244% | +$719K |
|
|
DOO
3496
Bombardier Recreational Products
DOO
$4.73B
| $1.08M | ﹤0.01% |
+23,015
| New | +$1.07M |
|
3497
Liberty Latin America Class C
LILAK
$1.66B
| $1.08M | ﹤0.01% |
61,099
+51,341
| +526% | +$866K |
|
3498
CALL
Opko Health
OPK
$1B
| $1.08M | ﹤0.01% |
311,600
+106,800
| +52% | +$567K |
|
|
GTY
3499
Getty Realty Corp
GTY
$2.06B
| $1.08M | ﹤0.01% |
37,671
+25,634
| +213% | +$737K |
|
3500
Matrix Service
MTRX
$329M
| $1.07M | ﹤0.01% |
43,477
+32,115
| +283% | +$679K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.